COVID-19 Survey Reports: Health & Rights of People who Use Drugs in a COVID-19 Environment
During the COVID-19 pandemic, INPUD has committed ourselves to supporting our global community through the collection and reporting of information on the experiences of people who use drugs via an online survey. Our peer-driven research seeks:
- To understand how people who use drugs experience and emerge from COVID-19 induced change, disruptions and official emergency powers.
- To document and monitor human rights violations, service disruptions and other difficulties experienced by people who use drugs associated with COVID-19 responses.
- To capture and document the adoption of responses that address the needs of people who use drugs to inform advocacy and to protect these gains in the post-COVID-19 environment.
Below you will find reports compiled from survey responses in two phases of data collection. We intend to keep the survey open for responses and continue to generate reports so long as the pandemic remains an obstacle to the full enjoyment of health and rights to people who use drugs.
DATA REPORT 1: 8th May -31st May 2020
DATA REPORT 2: 1 June - 31 July 2020
The data presented is a brief overview and summary of initial data across all six languages of the survey. Data analysis was conducted using automatically generated Survey Monkey data summary reports for the quantitative results and a qualitative thematic analysis approach to identify the key themes within each language version and the collated data set. Data collection is ongoing and further data analysis and reports will be produced in due course. This data report is designed to provide a brief overview of the data collected and some of the key emerging issues. For this reason, not all available data is included in the analysis below.
Country specific data has been provided for some responses to provide context, but this should not be taken to mean that the issues reported have not occurred in other settings.
This brief report includes:
1. Overview of the total sample;
2. Data on 3 specific COVID-19 questions on testing and awareness of cases;
3. Brief qualitative summary of key themes and issues from 4 key sections of survey on:
a. Health and Harm Reduction;
b. Drug Use and Safe Supply;
c. Drug Laws and Detention; and
d. Protecting Human Rights.